Logo image of SPRY

ARS PHARMACEUTICALS INC (SPRY) Stock Earnings & Estimates

USA - NASDAQ:SPRY - US82835W1080 - Common Stock

9.8 USD
+0.26 (+2.73%)
Last: 9/26/2025, 8:00:02 PM
9.86 USD
+0.06 (+0.61%)
Pre-Market: 9/29/2025, 6:54:37 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
SPRY revenue by date.SPRY revenue by date.
1.32M30K
-97.73%
89.149M
297,063.33%
83.432M
-6.41%
241.05M
188.92%
418.96M
73.81%
522.61M
24.74%
771.02M
47.53%
1.076B
39.56%
990.17M
-7.98%
1.111B
12.20%
EBITDA
YoY % growth
SPRY ebitda by date.SPRY ebitda by date.
-35.2M
60.36%
-67.447M
-91.61%
-3.004M
95.55%
-150.236M
-4,901.19%
-14.637M
90.26%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
SPRY ebit by date.SPRY ebit by date.
-35.52M
60.35%
-67.52M
-90.09%
-3.083M
95.43%
-176.091M
-5,611.67%
-79.826M
54.67%
49.693M
162.25%
142.38M
186.52%
336.57M
136.39%
615.75M
82.95%
301.92M
-50.97%
408M
35.14%
Operating Margin
SPRY operating margin by date.SPRY operating margin by date.
-2,690.91%-225,066.67%-3.46%-211.06%-33.12%11.86%27.24%43.65%57.23%30.49%36.72%
EPS
YoY % growth
SPRY eps by date.SPRY eps by date.
-0.98
61.72%
-0.57
41.84%
0.05
108.77%
-1.68
-3,452.39%
-0.80
52.43%
0.49
161.83%
1.25
154.48%
0.93
-26.02%
1.65
78.02%
2.46
48.77%
3.33
35.27%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.48
-138.85%
-0.37
-175.63%
-0.37
-5.64%
-0.25
45.12%
-0.09
81.32%
-0.17
53.90%
-0.09
75.17%
0.12
148.48%
0.40
545.71%
0.12
171.64%
Revenue
Q2Q % growth
29.168M
1,310.44%
31.333M
-63.81%
34.433M
331.87%
55.65M
254.08%
74.352M
154.91%
51.024M
62.84%
70.278M
104.10%
106.8M
91.91%
157.64M
112.02%
101.07M
98.08%
EBITDA
Q2Q % growth
-38.801M
-78.82%
-38.597M
-181.64%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-49.415M
-127.22%
-39.964M
-184.67%
-36.036M
3.07%
-28.533M
40.07%
-3.327M
93.27%
-34.207M
14.41%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.46
-253.85%
-0.480.024.05%
Q1 2025
Q2Q % growth
-0.35
-218.18%
-0.350.001.02%
Q4 2024
Q2Q % growth
0.49
800.00%
-0.140.63443.14%
Q3 2024
Q2Q % growth
-0.20
-25.00%
-0.15-0.05-32.93%
Q2 2024
Q2Q % growth
-0.13
27.78%
-0.12-0.01-9.24%
Q1 2024
Q2Q % growth
-0.11
31.25%
-0.110.001.96%
Q4 2023
Q2Q % growth
-0.07
-109.09%
-0.140.0750.98%
Q3 2023
Q2Q % growth
-0.16
68.00%
-0.190.0314.13%
Q2 2023
Q2Q % growth
-0.18
67.27%
-0.180.00-1.61%
Q1 2023
Q2Q % growth
-0.16
77.14%
-0.170.016.45%
Q4 2022
Q2Q % growth
0.77
214.93%
-0.130.90680.69%
Q3 2022
Q2Q % growth
-0.50
23.08%
-0.36-0.14-38.08%
Q2 2022
Q2Q % growth
-0.55
21.43%
-0.49-0.06-11.56%
Q1 2022
Q2Q % growth
-0.70
-29.63%
-0.55-0.15-28.04%
Q4 2021
Q2Q % growth
-0.67
51.09%
-0.720.056.43%
Q3 2021
Q2Q % growth
-0.65 -0.690.045.45%
Q2 2021
Q2Q % growth
-0.70 -0.54-0.16-28.68%
Q1 2021
Q2Q % growth
-0.54 -0.36-0.18-49.13%
Q4 2020
Q2Q % growth
-1.37 -0.50-0.87-174.11%
SPRY Yearly EPS VS EstimatesSPRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2 3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
15.717M
3,043.40%
14.052M1.665M11.85%
Q1 2025
Q2Q % growth
7.973M 7.631M342K4.48%
Q4 2024
Q2Q % growth
86.581M 16.134M70.447M436.64%
Q3 2024
Q2Q % growth
2.068M 586.5K1.482M252.60%
Q2 2024
Q2Q % growth
500K
4,900.00%
1.02M-520K-50.98%
Q1 2024
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth
1.32M 96.39K1.224M1,269.44%
SPRY Yearly Revenue VS EstimatesSPRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.2% -16.12% -8.97% -11.54%
Revenue-0.17% -0.5% -2.7% -2.23%